Hopei Plans To Implement Medical Reforms Over The Next 3 Years With Supporting Funds Of RMB 34.5 Billion
This article was originally published in PharmAsia News
Executive Summary
Hopei province will grant funds to carry out medical reforms, focusing on five core reforms: speeding up development of the basic medical insurance system to increase the rate of insured residents to over 90 percent within three years, preliminarily establishing the national essential medicines system, gradually achieving equalization of basic public health services, strengthening the primary care service system, and accelerating the public hospital pilot reform. (Click here for more - Chinese language) "Hopei Province Will Spend RMB 34.5 Billion In New Medical Reform Within 3 Years"--xinhuanet.com (9/3/2009
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.